Concord Wealth Partners’s Harvard Bioscience HBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-750	Closed	-$2.02K	–	953
2024 Q3	$2.02K	Buy	+750	New	+$2.02K	﹤0.01%	743
2024 Q2	–	Sell	-2,250	Closed	-$9.54K	–	877
2024 Q1	$9.54K	Buy	+2,250	New	+$9.54K	﹤0.01%	576